Related references
Note: Only part of the references are listed.Molecular Pathways: CDK4 Inhibitors for Cancer Therapy
Mark A. Dickson
CLINICAL CANCER RESEARCH (2014)
Signaling through cyclin D-dependent kinases
Y. J. Choi et al.
ONCOGENE (2014)
CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence Duration of cell cycle arrest and MTOR activity determine geroconversion
Olga V. Leontieva et al.
CELL CYCLE (2013)
MEK drives cyclin D1 hyperelevation during geroconversion
O. V. Leontieva et al.
CELL DEATH AND DIFFERENTIATION (2013)
Phase II Trial of the CDK4 Inhibitor PD0332991 in Patients With Advanced CDK4-Amplified Well-Differentiated or Dedifferentiated Liposarcoma
Mark A. Dickson et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
A Cdk7-Cdk4 T-Loop Phosphorylation Cascade Promotes G1 Progression
Miriam Merzel Schachter et al.
MOLECULAR CELL (2013)
Blockbuster dreams for Pfizer's CDK inhibitor
Malini Guha
NATURE BIOTECHNOLOGY (2013)
CDK4 T172 Phosphorylation Is Central in a CDK7-Dependent Bidirectional CDK4/CDK2 Interplay Mediated by p21 Phosphorylation at the Restriction Point
Xavier Bisteau et al.
PLOS GENETICS (2013)
Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma
John P. Leonard et al.
BLOOD (2012)
The Requirement for Cyclin D Function in Tumor Maintenance
Yoon Jong Choi et al.
CANCER CELL (2012)
Therapeutic Targeting of the Cyclin D3:CDK4/6 Complex in T Cell Leukemia
Catherine M. Sawai et al.
CANCER CELL (2012)
Gains in FGF19 are predictive of response to the fibroblast growth factor receptor (FGFR) small molecule tyrosine kinase inhibitor BGJ 398 in vitro
Richard S. Finn et al.
CANCER RESEARCH (2012)
Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors
Jeffry L. Dean et al.
CELL CYCLE (2012)
Regulation of p27Kip1 by mitogen-induced tyrosine phosphorylation
Heidelinde Jaekel et al.
CELL CYCLE (2012)
Cdk4/6 Inhibition Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness in Pancreatic Cancer Cells
Fang Liu et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1)
G. K. Schwartz et al.
BRITISH JOURNAL OF CANCER (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21
Yuefeng Wang et al.
NATURE CHEMICAL BIOLOGY (2011)
A Synthetic Lethal Interaction between K-Ras Oncogenes and Cdk4 Unveils a Therapeutic Strategy for Non-small Cell Lung Carcinoma
Marta Puyol et al.
CANCER CELL (2010)
Pharmacologic Inhibition of Cyclin-Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts
Karine Michaud et al.
CANCER RESEARCH (2010)
Rb inactivation in cell cycle and cancer The puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase
Sabine Paternot et al.
CELL CYCLE (2010)
Targeting the RB-pathway in Cancer Therapy
Erik S. Knudsen et al.
CLINICAL CANCER RESEARCH (2010)
cAMP-Dependent Activation of Mammalian Target of Rapamycin (mTOR) in Thyroid Cells. Implication in Mitogenesis and Activation of CDK4
Sara Blancquaert et al.
MOLECULAR ENDOCRINOLOGY (2010)
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
Poulikos I. Poulikakos et al.
NATURE (2010)
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
Georgia Hatzivassiliou et al.
NATURE (2010)
Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure
J. L. Dean et al.
ONCOGENE (2010)
Combined Inhibition of MEK and Mammalian Target of Rapamycin Abolishes Phosphorylation of Cyclin-Dependent Kinase 4 in Glioblastoma Cell Lines and Prevents Their Proliferation
Sabine Paternot et al.
CANCER RESEARCH (2009)
p27Kip1 Inhibits Cyclin D-Cyclin-Dependent Kinase 4 by Two Independent Modes (Publication with Expression of Concern. See vol. 42, 2022)
Arpita Ray et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Differential Regulation of Cyclin-Dependent Kinase 4 (CDK4) and CDK6, Evidence that CDK4 Might Not Be Activated by CDK7, and Design of a CDK6 Activating Mutation
Laurence Bockstaele et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Cell cycle, CDKs and cancer: a changing paradigm
Marcos Malumbres et al.
NATURE REVIEWS CANCER (2009)
Cyclic AMP Inhibits the Proliferation of Thyroid Carcinoma Cell Lines through Regulation of CDK4 Phosphorylation
Ana Sofia Rocha et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Pharmacologic inhibition of CDK4/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemia
Lisheng Wang et al.
BLOOD (2007)
Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases
Matthias Grimmler et al.
CELL (2007)
A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6
Linda B. Baughn et al.
CANCER RESEARCH (2006)
Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): Its relationship with cyclins and CDK inhibitors
Laurence Bockstaele et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation
Cyril Berthet et al.
DEVELOPMENTAL CELL (2006)
Distinct specificities of pRb phosphorylation by CDK4 activated by cyclin D1 or cyclin D3 - Differential involvement in the distinct mitogenic modes of thyroid epithelial cells
S Paternot et al.
CELL CYCLE (2006)
Cdk2-dependent inhibition of p21 stability via a C-terminal cyclin-binding motif
HY Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6
PL Toogood et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro
T Takaki et al.
JOURNAL OF BIOCHEMISTRY (2005)
Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexes
K Kozar et al.
CELL CYCLE (2005)
Mammalian cells cycle without the D-type cyclin-elependent kinases Cdk4 and Cdk6
M Malumbres et al.
CELL (2004)
p27Kip1 and p21Cip1 are not required for the formation of active D cyclin-cdk4 complexes
TK Bagui et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells
S Paternot et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase
G Bornstein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Activation of cyclin DI-kinase in murine fibroblasts lacking both p21Cip1 and P27Kip1
M Sugimoto et al.
ONCOGENE (2002)
Cyclin D-dependent kinases, INK4 inhibitors and cancer
S Ortega et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2002)
p21Cip1 promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export
JR Alt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence
J Lin et al.
ONCOGENE (2001)
Analysis of cyclin D3-cdk4 complexes in fibroblasts expressing and lacking p27kip1 and p21cip1
TK Bagui et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
